<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="platform">4</item><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM694344 1"/></item></item><item key="id">4005</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-28089</item><item key="summary_wrapped">IPH-926 is an anticancer drug-resistant tumor cell line derived from a chemo-refractory human infiltrating lobular breast cancer (ILBC)....</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">1</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>line</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">iph-926-human-lobular-breast-cancer-cells</item><item key="geo_id_plat">E-GEOD-28089_A-AFFY-44</item><item key="name">IPH-926 human lobular breast cancer cells</item><item key="created">Sep.15, 2014</item><item key="summary">IPH-926 is an anticancer drug-resistant tumor cell line derived from a chemo-refractory human infiltrating lobular breast cancer (ILBC). IPH-926 ILBC cells were subjected to gene expression profiling using an Affymetrix HG U133 Plus 2.0 array. To characterize the global gene expression of IPH-926, cells were subjected to transcriptional profiling using the Affymetrix HG U133 Plus 2.0 technology. The correct identity of the IPH-926 cells subjected to gene expression profiling was authenticated by short tandem repeat (STR) profiling.</item><item key="geo_gse_id">E-GEOD-28089</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-28089/samples/</item></data></biogps>
